F Reimann, PS Ward, FM Gribble - Diabetes, 2006 - Am Diabetes Assoc Glucagon-like peptide-1 (GLP-1) is released from intestinal L-cells in response
to a range of nutrients, hormones, and neurotransmitters. Its potency as an
insulin secretagogue has led to pharmaceutical interest in developing ... Cited by 10 - Related articles - BL Direct - All 4 versions
F Reimann, M Maziarz, G Flock, AM Habib, DJ … - The Journal of Physiology, 2005 - Physiological Soc Glucagon-like peptide-1 (GLP-1) is released from intestinal L-cells in response
to nutrient ingestion. It is currently under therapeutic evaluation because it
enhances insulin secretion in type 2 diabetes. Previous studies using the ... Cited by 9 - Related articles - BL Direct - All 11 versions
K Matsumura, T Miki, T Jhomori, T Gonoi, S … - Biochemical and Biophysical Research …, 2005 - Elsevier Oligopeptides originating from ingested meal stimulate the secretion of various
gastrointestinal hormones, but the mechanism is unknown. In this study, we show
that transfection of oligopeptide transporter 1 (PEPT1) in STC-1 cells, a ... Cited by 5 - Related articles - All 4 versions
F Reimann, L Williams, G da Silva Xavier, GA … - Diabetologia, 2004 - Springer Aims/hypothesis. Glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) are
secreted from enteroendocrine L cells in response to nutrient ingestion. As
glutamine is an important metabolic fuel for the gut, the aim of this study ... Cited by 23 - Related articles - BL Direct - All 6 versions
- ►nih.gov H Bara, A Sambanis - Biochemical and biophysical research communications, 2008 - Elsevier Cell-based treatments for insulin-dependent diabetes (IDD) may provide more
physiologic regulation of blood glucose levels than daily insulin injections,
thereby reducing the occurrence of secondary complications associated with ... Cited by 3 - Related articles - All 3 versions
GE Lim, GJ Huang, N Flora, D LeRoith, CJ … - Endocrinology, 2009 - Endocrine Soc Insulin resistance and type 2 diabetes mellitus are associated with impaired
postprandial secretion of glucagon-like peptide-1 (GLP-1), a potent
insulinotropic hormone. The direct effects of insulin and insulin ... Cited by 4 - Related articles - All 3 versions
AK Simpson, PS Ward, KY Wong, GJ Collord, … - Diabetologia, 2007 - Springer Abstract Aims/hypothesis To investigate the pathways by which cyclic AMP (cAMP)
stimulates glucagon-like peptide-1 (GLP-1) secretion, using the GLUTag
enteroendocrine cell line. Materials and methods GLP-1 release from GLUTag ... Cited by 10 - Related articles - BL Direct - All 3 versions
- ►nih.gov F Reimann, AM Habib, G Tolhurst, HE Parker, … - Cell Metabolism, 2008 - Elsevier Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based
treatments are clinically available, alternative strategies to increase ... Cited by 10 - Related articles - All 11 versions
JC Gevrey, M Malapel, J Philippe, G Mithieux, … - Diabetologia, 2004 - Springer Aims/hypothesis. Protein hydrolysates (peptones) in- crease not only
glucagon-like peptide-1 (GLP-1) se- cretion but also transcription of the
proglucagon (PG) gene in the intestine. The critical physiological roles of ... Cited by 19 - Related articles - BL Direct - All 4 versions
- ►physiology.org KK Papas, MAC Jarema - American Journal of Physiology- Endocrinology And …, 1998 - Am Physiological Soc We investigated the effects of glucose on the rates of oxygen consumption (OCR)
and insulin secretion (ISR) by HC9 cells derived from mouse pancreatic islets
with -cell hyperplasia. Our results demonstrate that the OCR by HC9 cells ... Cited by 12 - Related articles - BL Direct - All 5 versions
